Comparative analysis of antiangiogenic and immunotherapeutic regimens in the treatment of metastatic pulmonary lymphoepithelioma-like carcinoma

Abstract Background and Objective Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare histological subtype of non-small cell lung cancer for which no standard treatment protocol exists in the metastatic setting. This study aims to evaluate the efficacy and safety of antiangiogenic agents an...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Fu-Lian Qu, Yao-Hong Gao, Yan Zhang, Hong-Rui Zhang, Ya-Zhen Hong, Xiao-Jing Tie, Pei-Jie Liu
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMC 2025-07-01
Cyfres:	Journal of Cardiothoracic Surgery
Pynciau:	Anti-tumor angiogenesis drugs Cytotoxic drugs Epstein-Barr virus (EBV) Immune checkpoint inhibitors (ICIs) Pulmonary lymphoepithelioma-like carcinoma (PLELC)
Mynediad Ar-lein:	https://doi.org/10.1186/s13019-025-03534-3
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!